The effectiveness and cost-effectiveness of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) for trauma

Not Applicable

Completed

• Conditions: ife-threatening torso haemorrhage; Injury, Occupational Diseases, Poisoning

• Registration Number: ISRCTN16184981
• Lead Sponsor: niversity of Aberdeen and NHS Grampian

Brief Summary

2022 Interim results article in https://pubmed.ncbi.nlm.nih.gov/35550599/ (added 16/05/2022) 2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35550642/ (added 16/05/2022) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37824132/ (added 16/10/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-08-23
• Study Completion: 2023-03-31
• Last Update Posted: 30 October 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

1. Adult trauma patients (aged, or believed to be aged, 16 or older)
2. Confirmed or suspected life-threatening torso haemorrhage which is thought to be amenable to adjunctive treatment with REBOA (zone I or zone III)

Exclusion Criteria

1. Women known or thought to be pregnant at presentation
2. Children (aged, or believed to be aged 15 or younger)
3. Patients with injuries which are deemed unsurvivable on clinical grounds

Study & Design

• Study Type: Interventional
• Study Design: Not specified